Who has invested in Tempero Bio?

8VC, Aditum Bio, Khosla Ventures are named among the investors backing Tempero Bio.

Tempero Bio Funding: $70M Raised, Series B (2025)

Tempero Bio funding overview

Tempero Bio is based in Oakland, California. Tempero Bio has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2025. The round record for Tempero Bio runs through 2025; nothing later has been disclosed. Investors on record include 8VC, Aditum Bio, Khosla Ventures. 3 distinct backers are named across the disclosed rounds.

Tempero Bio at a glance

Total raised: $70M
Latest round: Series B
Latest round date: March 2025
Headquarters: Oakland, California
Notable investors: 8VC, Aditum Bio, Khosla Ventures

Frequently asked about Tempero Bio funding

How much has Tempero Bio raised?: Tempero Bio has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Tempero Bio?: 8VC, Aditum Bio, Khosla Ventures are named among the investors backing Tempero Bio.
What was the latest Tempero Bio funding round?: The most recent disclosed round is a Series B, announced in March 2025.
Where is Tempero Bio based?: Tempero Bio is based in Oakland, California.
When did Tempero Bio last raise?: The last disclosed Tempero Bio round closed in March 2025 at Series B.

Tempero Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Oakland below to benchmark round size and investor mix.

Tempero Bio Funding: $70M Raised, Series B (2025)

Tempero Bio funding overview

Tempero Bio at a glance

Frequently asked about Tempero Bio funding

Companies related to Tempero Bio (36)

Browse related funding lists (4)